reference/12700767

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12700767

Outgoing Links

Predicate	Object
contentType	Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	923
issn	1340-3478 1880-3873
issueIdentifier	10
pageRange	914-923
publicationName	Journal of Atherosclerosis and Thrombosis
startingPage	914
bibliographicCitation	Lee SP, Park KW, Shin DH, Lee HY, Kang HJ, Koo BK, Suh JW, Youn TJ, Choi DJ, Chae IH, Kim HS. Efficacy of predicting thrombotic events with combination of dual point-of-care testing (POCT) after drug-eluting stent implantation for coronary heart disease: results from the CILON-T randomized trial POCT substudy. J Atheroscler Thromb. 2011;18(10):914–23. doi: 10.5551/jat.9290. PMID: 21791883.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_85fb73e7dc292cdcb2f3f0ab5965e6d4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_82fc155b6e79b2cf7229e82904da20cc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a93fd031e39095631e1745297fd4203b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6f1e0b68e341dd74d5b5ddd2cb4670f3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6299b016ff8ea290238b197a4b7b05d4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5f94b5f26ba4d650531926ef40752409 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9b98675c3802fdd0732840d6a22a0fea http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9bf4564c65a6592bf6a0677af1241cc5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1b6ad64a037c94fed06c6526be10f8ec http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a8edf072a2e77851eb580b1808fa6cbe http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cbf9071096ea3199ef0295441f0510f5
date	2011
identifier	https://doi.org/10.5551/jat.9290 https://pubmed.ncbi.nlm.nih.gov/21791883
isPartOf	https://portal.issn.org/resource/ISSN/1880-3873 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/20646 https://portal.issn.org/resource/ISSN/1340-3478
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Efficacy of Predicting Thrombotic Events with Combination of Dual Point-of-Care Testing (POCT) after Drug-Eluting Stent Implantation for Coronary Heart Disease: Results from the CILON-T Randomized Trial POCT Substudy
discusses	http://id.nlm.nih.gov/mesh/M0017012
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D054855 http://id.nlm.nih.gov/mesh/D019095 http://id.nlm.nih.gov/mesh/D003327Q000601 http://id.nlm.nih.gov/mesh/D013927Q000209
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D010975Q000627 http://id.nlm.nih.gov/mesh/D011446 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D003327Q000188 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D006801
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6746 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8564 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f74135abcce785031995f1a87552cf78 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9412 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7347

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127563695

Total number of triples: 50.